Company: FTII
Filing Date: 2025-02-14
Form Type: S-4
Source: 0001493152-25-006997
Chunk: 217

Company: FutureTech II Acquisition Corp.
Filing Date: 2025-02-14
Form: S-4
Chunk 217
---
                          |

| ● | take any action that would reasonably be expected to significantly delay or impair the obtaining of any 
 consents of any governmental authority to be obtained in connection with the Merger Agreement;          |

| ● | accelerate the collection of any trade receivables or delay the payment of trade payables or any other                                          
 liabilities other than in the ordinary course of business consistent with past practice; enter into, amend, waive or terminate (other           
 than terminations in accordance with their terms) any transaction with any related person (other than compensation and benefits and advancement 
 of expenses, in each case, provided in the ordinary course of business consistent with past practice); or                                       |

| ● | authorize or agree to do any action prohibited by the Merger Agreement. |

FutureTech has
agreed that, unless otherwise required or permitted under the Merger Agreement, and subject to certain disclosed exceptions, FutureTech
will take the following actions during the interim period between signing of the Merger Agreement and Closing, among others, without the
prior written consent of Longevity (which consent will not be unreasonably conditioned, withheld, delayed or denied):

| ● | amend, waive or otherwise change, in any respect, its organizational documents except as required by applicable 
 law;                                                                                                            |

| ● | authorize for issuance, issue, grant, sell, pledge, dispose of or propose to issue, grant, sell, pledge                                         
 or dispose of any of its equity securities or any options, warrants, commitments, subscriptions or rights of any kind to acquire or sell        
 any of its equity securities, or other securities, including any securities convertible into or exchangeable for any of its equity securities   
 or other security interests of any class and any other equity-based awards, other than the issuance of any FutureTech Units, FutureTech         
 Common Stock, or FutureTech Warrants (together, “FutureTech Securities”) issuable upon conversion or exchange of outstanding                    
 FutureTech Securities in accordance with their terms, or engage in any hedging transaction with a third Person with respect to such securities; |

| ● | split, combine, recapitalize or reclassify any of its shares or other equity interests or issue any other                                    
 securities in respect thereof or pay or set aside any dividend or other distribution (whether in cash, equity or property or any combination 
 thereof) in respect of its shares or other equity interests, or directly or indirectly redeem, purchase or otherwise acquire or offer        
 to acquire any of its securities;                                                                                                            |

| 107 |